Sanara MedTech Inc. — Third Quarter 2026 Earnings Summary

Sanara MedTech Inc. reported third-quarter 2026 net revenue of $28.4 million, an 8% increase from the prior year, driven by growth in soft tissue repair products. The company posted a net loss from continuing operations of $1.3 million, or $0.15 per diluted share, compared to a net income of $0.8 million in the same period last year. Adjusted EBITDA for the quarter rose to $5.6 million, while the company updated its full-year 2026 revenue guidance to a range of $110 million to $115 million. Additionally, Sanara continues to advance its pending merger with MiMedx Group, Inc., which received shareholder approval in September.